Skip to Content

Lidocaine Hydrochloride and 5% Dextrose injection

Last Updated: February 15, 2018
Status: Resolved

Lidocaine Hydrochloride and 5% Dextrose injection

Products Affected - Description
  • Lidocaine and 5% Dextrose injection, BBraun
    4 mg/mL, 250 mL premixed bag, 1 count (NDC 00264-9594-20)
    4 mg/mL, 500 mL premixed bag, 1 count (NDC 00264-9594-10)
    8 mg/mL, 250 mL premixed bag, 1 count (NDC 00264-9598-20)

 
Lidocaine and 5% Dextrose injection, Baxter
4 mg/mL, 500 mL premixed bag, 18 count (NDC 00338-0409-03)
8 mg/mL, 250 mL premixed bag, 24 count (NDC 00338-0411-02)
Reason for the Shortage
    • Baxter did not provide a reason for the shortage.
    • BBraun did not provide a reason for the shortage.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Baxter has lidocaine and 5% dextrose 4 mg/mL 500 mL and 8 mg/mL 250 mL premixed bags on back order and the company cannot estimate a release date.
    • BBraun has lidocaine and 5% dextrose 4 mg/mL 250 mL, 4 mg/mL 500 mL, and 8 mg/mL 250 mL premixed bags on intermittent back order and supplies are being allocated upon release.

Updated

February 15, January 3, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide